甲状腺髓样癌肝转移的非典型表现:18F-FDG、68Ga-DOTATATE与68Ga-DOTA-FAPI-04 PET/CT所见可变模式与病灶间异质性
报告一例50岁男性进展期甲状腺髓样癌患者,左肝叶出现非典型低密度转移灶,在常规18F-FDG和68Ga-DOTATATE PET/CT上无示踪剂摄取,而在68Ga-DOTA-FAPI-04 PET/CT上呈高摄取,提示FAPI PET/CT可能有助于诊断常规PET可能漏诊的不寻常转移灶,并具有未来诊疗的潜力。
要点
- 甲状腺髓样癌肝转移可表现不一,原文提及肝转移发生率高达62%。
- 本例左肝叶低密度转移灶在18F-FDG和68Ga-DOTATATE PET/CT上无摄取。
- 同一病灶在68Ga-DOTA-FAPI-04 PET/CT上呈高摄取,提示病灶间异质性。
核心结论
- 甲状腺髓样癌肝转移可表现不一,本例左肝叶非典型低密度转移灶在常规18F-FDG和68Ga-DOTATATE PET/CT上无摄取,而在68Ga-DOTA-FAPI-04 PET/CT上呈高摄取。
- 作者认为FAPI PET/CT可能有助于诊断常规PET可能漏诊的不寻常转移灶,并具有未来诊疗的潜力。
研究设计与样本
- 病例报告:一例50岁男性进展期甲状腺髓样癌患者。
主要发现
- 患者左肝叶出现非典型低密度转移灶,在18F-FDG和68Ga-DOTATATE PET/CT上无示踪剂摄取。
- 该病灶在68Ga-DOTA-FAPI-04 PET/CT上呈高摄取。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metastatic medullary thyroid carcinoma (MTC) can exhibit variable progression, with liver metastases occurring in up to 62% of cases. We report an unusual case of 50-year-old man with progressive MTC and atypical hypodense metastasis in the left lobe of liver that showed no tracer avidity on conventional 18 F-FDG and 68 Ga-DOTATATE PET/CT but was intensely avid on 68 Ga-DOTA-FAPI-04 PET/CT, implying a possible role of FAPI PET/CT imaging in diagnosing unusual metastatic lesions that may be missed on conventional PET imaging and also its theranostic potential for future management.
引用
- Ravada SK, Parghane RV, Malhotra G, et al. Atypical Presentation of Liver Metastasis in Medullary Thyroid Carcinoma: Variable Pattern and Interlesional Heterogeneity Observed on 18 F-FDG, 68 Ga-DOTATATE, and 68 Ga-DOTA-FAPI-04 PET/CT. Clin Nucl Med. 2025. PMID: 40392188. doi:10.1097/RLU.0000000000005965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。